Icon

EMBEDA (nda022321)- (20MG;0.8MG,30MG;1.2MG,50MG;2MG,60MG;2.4MG,80MG;3.2MG,100MG;4MG)

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE ALPHARMA PHARMS
20MG;0.8MG,30MG;1.2MG,50MG;2MG,60MG;2.4MG,80MG;3.2MG,100MG;4MG
Yes Yes
2029-Nov-07 Expired
None None
None No
EMBEDA is a combination opioid agonist/opioid antagonist product indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
0 0 0
Total Other Developers None
Drugs with Suitability No
20MG;0.8MG ** ** - - -
30MG;1.2MG ** ** - - -
50MG;2MG ** ** - - -
60MG;2.4MG ** ** - - -
80MG;3.2MG ** ** - - -
100MG;4MG ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

GenUs Advanced Search




Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.